Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Turning Stem Cells from Fat into Blood Vessels

By LabMedica International staff writers
Posted on 13 Aug 2012
Autologous adult stem cells extracted via liposuction from fat tissue can provide the raw materials for growing tissue-engineered blood vessel (TEBV) in the lab, according to a new study.

Researchers at the University of Oklahoma (Norman, USA) first differentiated adipose-derived stem cells into smooth muscle cells (SMCs), and then seeded them onto a flat sheet of the human amniotic membrane--a very thin collagen membrane--used as a biological substrate to fabricate the small-diameter TEBVs. More...
To develop a tubular construct similar to that of a muscular artery's tunica media layer, the cell-seeded sheet was wrapped around a 3-mm removable mandrel with six to seven revolutions. After a two-week static culture period, the fabricated TEBV was assessed for biochemical and mechanical properties.

The researchers examined and compared the contraction of the vessel in response to carbachol--a specific agonist for SMCs--to that of porcine coronary arteries; burst pressure and elastic modulus tests were also conducted. The researchers found that the thickness and architecture of the engineered vessel matched that of a porcine coronary artery in a histological analysis; it also performed better than the porcine vessel for elasticity in a tensile strength test. However, the burst pressure was too low, at about 150 mm Hg, while native tissue withstands 1,000 mm Hg. The problem, according to the researchers, appeared to be that the layers of the rolled-up vessel are not adhering well to one another.

The researchers found that the mechanical integrity of the construct could be further improved by exposure to appropriate physiological conditions in a perfusion bioreactor, and that adipose-derived endothelial cells also could be seeded into the lumen of the construct to prevent platelet adhesion. The study was presented at the American Heart Association Basic Cardiovascular Sciences 2012 scientific sessions, held during July 2012 in New Orleans (LA, USA).

“These liposuction-derived vessels, grown in a lab, could help solve major problems associated with grafting blood vessels from elsewhere in the body or from using artificial blood vessels that are not living tissue,” concluded lead author and study presenter Matthias Nollert, PhD, and colleagues of the school of chemical, biological, and materials engineering. “Our engineered blood vessels have good mechanical properties and we believe they will contract normally when exposed to hormones.”

Related Links:

University of Oklahoma




Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.